TrialCancer science2007

Phase II study of the irinotecan (CPT-11), mitoxantrone and dexamethasone regimen in elderly patients with relapsed or refractory peripheral T-cell lymphoma.

Nozomi Niitsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.